Literature DB >> 17988988

Frequent detection of multidrug-resistant pneumonia-causing bacteria in the pneumonia lung tissues of patients with hematological malignancies.

Kunihiro Inai1, Hiromichi Iwasaki, Sakon Noriki, Satoshi Ikegaya, Masanori Yamashita, Yoshiaki Imamura, Nobuo Takimoto, Hisataka Kato, Takanori Ueda, Hironobu Naikia.   

Abstract

Pneumonia is a critical issue during the agonal phase, and often becomes lethal in the absence of pathogen detection. Autopsy is a powerful tool for analyzing the cause of a patient's death, progression of the disease, and the therapeutic response. However, it is frequently limited to the identification of bacterial strains. To elucidate the pathogenesis during the agonal phase of pneumonia, intrapulmonary sputum was harvested by directly inserting a swab into a resected lung, and the bacterial composition was analyzed using both pathological and microbiological techniques from 15 patients with hematological malignancies, and the results were compared with those from 25 patients with other medical and surgical diseases. Among the 54 bacteria strains isolated from the 40 patients, multidrug-resistant strains were significantly more prevalent in hematological group than in other diseases (16/21 versus 11/33, P = .002). Enterococcus faecium was preferentially isolated from the hematological patients, whereas the methicillin-resistant Staphylococcus aureus was predominantly found in the nonhematological group. Two coagulase-negative Staphylococcus epidermidis strains in hematological diseases may be diagnosed as causative bacteria of pneumonia by both bacterial and pathological techniques. Although the results of this study may not be directly applicable for clinical diagnosis, this approach has a potential to become not only a diagnostic method for bacterial pneumonia, but may be also useful for the analysis of multidrug-resistant pathogens.

Entities:  

Mesh:

Year:  2007        PMID: 17988988     DOI: 10.1532/IJH97.07233

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  27 in total

1.  Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites.

Authors:  James J Rahal; Carl Urban; Sorana Segal-Maurer
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

Review 2.  Multidrug-resistant tuberculosis--can the tide be turned?

Authors:  A Zumla; J M Grange
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

3.  In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected].

Authors:  C L Wielders; M R Vriens; S Brisse; L A de Graaf-Miltenburg; A Troelstra; A Fleer; F J Schmitz; J Verhoef; A C Fluit
Journal:  Lancet       Date:  2001-05-26       Impact factor: 79.321

Review 4.  How can immunology contribute to the control of tuberculosis?

Authors:  S H Kaufmann
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

5.  Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.

Authors:  Madonna J Matar; Jeffrey Tarrand; Issam Raad; Kenneth V I Rolston
Journal:  Am J Infect Control       Date:  2006-10       Impact factor: 2.918

6.  Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic.

Authors:  Gert Jan Timmers; Wil C van der Zwet; Ina M Simoons-Smit; Paul H M Savelkoul; Helena H M Meester; Christina M J E Vandenbroucke-Grauls; Peter C Huijgens
Journal:  Br J Haematol       Date:  2002-03       Impact factor: 6.998

7.  Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period.

Authors:  P Villari; C Sarnataro; L Iacuzio
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

Review 8.  The pathogenesis of sepsis.

Authors:  R C Bone
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

9.  Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci.

Authors:  A Sander; M Beiderlinden; E N Schmid; J Peters
Journal:  Intensive Care Med       Date:  2002-06-20       Impact factor: 17.440

10.  Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

Authors:  J C Wade; S C Schimpff; K A Newman; P H Wiernik
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

View more
  5 in total

Review 1.  Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.

Authors:  Justin L Wong; Scott E Evans
Journal:  Clin Chest Med       Date:  2017-03-01       Impact factor: 2.878

2.  Understanding the Concept of Health Care-Associated Pneumonia in Lung Transplant Recipients.

Authors:  Federico Palacio; Luis F Reyes; Deborah J Levine; Juan F Sanchez; Luis F Angel; Juan F Fernandez; Stephanie M Levine; Jordi Rello; Ali Abedi; Marcos I Restrepo
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

3.  Performance of a standardized bronchoalveolar lavage protocol in a comprehensive cancer center: a prospective 2-year study.

Authors:  Fotis Sampsonas; Dimitrios P Kontoyiannis; Burton F Dickey; Scott E Evans
Journal:  Cancer       Date:  2011-01-18       Impact factor: 6.860

4.  Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change.

Authors:  J Mebis; H Jansens; G Minalu; G Molenberghs; Wa Schroyens; Ap Gadisseur; A van de Velde; I Vrelust; H Goossens; Zn Berneman
Journal:  Infect Drug Resist       Date:  2010-07-28       Impact factor: 4.003

5.  Risk factor analysis for bone marrow histiocytic hyperplasia with hemophagocytosis: an autopsy study.

Authors:  Kunihiro Inai; Sakon Noriki; Hiromichi Iwasaki; Hironobu Naiki
Journal:  Virchows Arch       Date:  2014-05-23       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.